MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation, a global leader in bioluminescent technologies and cell-based assays, announces the launch of the CytoTox-Glo™ Cytotoxicity Assay at the 5th annual Screening Europe conference and exhibition. Whether monitoring chemical toxicity, anti-cancer drug efficacy or cytokine response, the CytoTox-Glo Assay provides a highly sensitive, simple, luminescent method that allows the user to detect small changes in cell viability.
